PT  - JOURNAL ARTICLE
AU  - Luís Cristóvão Porto
AU  - Claudia Henrique da Costa
AU  - Alessandra Sant’Anna Nunes
AU  - Isabel Bouzas
AU  - Tiago C. Ferreira
AU  - Vinicius M. Porto
AU  - Danielle A. Secco
AU  - Sandra P. C. Vilas Boas
AU  - Anamelia C. Faria
AU  - Rosangela A. G. Marins
AU  - Cíntia A. Duarte
AU  - Elizabeth P. Bittencourt
AU  - Anderson V. Loureiro
AU  - Angela Maria G. Santos
AU  - Vania Maria A. Souza
AU  - Fernanda H. Silva
AU  - Maria Cristina Lopes
AU  - Marcelle V. Castro
AU  - Areta D. Silva
AU  - Flavia M. Vasconcelos
AU  - Diego S. Moreira
AU  - Juliana P. Motta
AU  - Cristiano V. Lima
AU  - Raphaela S. Menezes
AU  - Nathalia B. V. Brazão
AU  - Jeane S. Nogueira
AU  - Ana Paula Villela Silva
AU  - Ingrid A.A. Brito
AU  - Scarlathe B. Costa
AU  - Roberta Mariana R. Lemes
AU  - Jessica Isis O. dePaula
AU  - Giovanna L. Bongionanni
AU  - Ohana C. L. Bezerra
AU  - Valter V. Andrade-Neto
AU  - Leonardo Morette
AU  - Rafael S. Barbosa
AU  - Jose Afonso L. Sanches
AU  - Pedro L. Melo
AU  - Sergio M. Freire
AU  - Romulo Souza
AU  - Laiz Gomes
AU  - Denize P. Felizardo
AU  - Alexsandre V. Rodrigues
AU  - Priscila A. Franco
AU  - Renata Miranda
AU  - Rogerio Rufino
TI  - Clinical and laboratory characteristics in outpatient diagnosis of COVID-19 in healthcare professionals in Rio de Janeiro, Brazil
AID  - 10.1101/2020.10.22.20217851
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.22.20217851
4099  - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20217851.short
4100  - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20217851.full
AB  - Aims This study aimed to identify the symptoms associated with early stage SARS-CoV-2 (COVID-19) infections in healthcare professionals (HCP) using both clinical and laboratory data.Methods A total of 1,297 patients, admitted between March 18 and April 8, 2020, were stratified according to their risk of developing COVID-19 using their responses to a questionnaire designed to evaluate symptoms and risk conditions.Results Anosmia/hyposmia (p <0.0001), fever (p<0.0001), body pain (p<0.0001), and chills (p=0.001) were all independent predictors for COVID-19, with a 72% estimated probability for detecting COVID-19 in nasopharyngeal swab samples. Leukopenia, relative monocytosis, decreased eosinophil values, CRP, and platelets were also shown to be significant independent predictors for COVID-19.Conclusions The significant clinical features for COVID-19 were identified as anosmia, fever, chills, and body pain. Elevated CRP, leukocytes under 5,400 x 109/L, and relative monocytosis (>9%) were common among patients with a confirmed COVID-19 diagnosis. These variables may help, in the absence of RT-PCR tests, to identify possible COVID-19 infections during pandemic outbreaks.Summary From March 19 to April 8 2020, 1,297 patients attended the Polyclinic Piquet Carneiro for COVID-19 detection. Healthcare professional data was analyzed, significant clinical features were anosmia, fever, chills and body pain. Elevated CRP, leukopenia and monocytosis were common in COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRio de Janeiro Research Support Agency (FAPERJ), National Council Research (CNPq). The Laboratory of Histocompatibility and Cryopreservation received a thermocycler and a -80C freezer from COVID-19 donation open account for Pedro Ernesto University Hospital. Rio de Janeiro Health Secretary provided nucleic acid extraction and RT-PCR kits.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Local and National Ethics Committee (CAAE: 30135320.0.0000.5259).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request.